Biobanking Market Research Report By Sample Type (Blood Products, Tissues, Cells, Nucleic Acids, Microbiome Samples), By Application (Research and Development, Clinical Trials, Personalized Medicine, Regenerative Medicine), By End-use (Academic Research Institutions, Biotechnology Companies, Pharmaceutical Companies, Government Organizations), By Storage Type (Vapor Phase Storage, Liquid Phase Storage, Cryopreservation Storage), and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2035

Global Biobanking Market Overview

As per MRFR analysis, the Biobanking Market Size was estimated at 4.93 (USD Billion) in 2023. The Biobanking Market is expected to grow from 5.14 (USD Billion) in 2024 to 8 (USD Billion) by 2035. The Biobanking Market CAGR (growth rate) is expected to be around 4.1% during the forecast period (2025 - 2035).

Key Biobanking Market Trends Highlighted

A number of important variables are propelling the notable expansion of the Biobanking Market. The growing need for targeted therapeutics and customized medicine, which necessitate large biobanks that supply a variety of biological samples, is one of the main factors propelling the market.

Global biobanking efforts are also being accelerated by developments in genomics and biotechnology, as nations make significant infrastructural investments to improve research capacities. Funding and policy support have increased as a result of governments and organizations realizing the value of biobanks for disease and public health research, which has aided in the growth of international biobank networks.

The Biobanking Market is experiencing a significant expansion in opportunities. Collaboration between pharmaceutical firms and biobanks has the potential to result in advances in drug development and a deeper comprehension of illnesses.

Furthermore, incorporating AI and machine learning into biobank operations can improve sample handling and data processing, generating new insights and efficiency. These new technologies provide biobanks a critical chance to boost their worth and research utility. Current patterns show that biobanking is moving toward uniform procedures and laws across geographical boundaries.

International research partnerships are facilitated by efforts to standardize sample collection, storage, and dissemination procedures, which enhance biorepositories' quality and credibility. Additionally, ethical issues and informed consent—which guarantees that participants are aware of how their biological samples will be used—are becoming more and more important.

Growing public knowledge of biobanks emphasizes the need of openness and participation, which will strengthen the foundation for biobanking projects in the long run. All of these patterns point to a vibrant and changing Biobanking Market.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Biobanking Market Drivers

Increasing Prevalence of Chronic Diseases

The Biobanking Market is significantly driven by the rising incidence of chronic diseases such as cancer, diabetes, and cardiovascular diseases. According to the World Health Organization, chronic diseases are responsible for approximately 71% of all deaths globally, with cancer cases projected to increase by about 60% over the next two decades.

Established organizations such as the American Cancer Society and the European Society for Medical Oncology have been actively promoting strategies for cancer research and patient management, which includes biobanking.

By providing vital biological samples for Research and Development (R&D), biobanks are crucial in understanding disease mechanisms and developing new therapeutic approaches. With the increasing focus on personalized medicine and targeted therapies, the demand for biobanking services is set to rise, further driving market growth in the Biobanking Market.

Advancements in Genomic Research

Advancements in genomic research and technologies are propelling the growth of the Biobanking Market. The completion of the Human Genome Project and ongoing research initiatives by entities like the National Institutes of Health have generated vast amounts of genomic data. As new genomic technologies proliferate, the demand for biological specimens for genetic analysis is expanding.

A report from the National Human Genome Research Institute has highlighted that the availability of biobanks is critical for advancing genomic and precision medicine, leading to tailor-made treatments based on individual genetic profiles. This shift towards personalized healthcare encourages the establishment and expansion of biobanks globally, thus bolstering market prospects.

Government Initiatives for Biobanking

Governments around the world are increasingly recognizing the importance of biobanking in healthcare and research, leading to supportive initiatives and policies. For instance, in 2022, the European Commission announced significant funding for biobanking projects aimed at facilitating research on rare diseases and precision medicine across Europe.

Such initiatives emphasize collaboration between public institutions and private sectors, thereby enhancing the operational landscape of the Biobanking Market. As governments invest in biobanking infrastructure and regulatory frameworks, the accessibility of biological samples improves, encouraging research partnerships and driving market growth.

Biobanking Market Segment Insights

Biobanking Market Sample Type Insights

The Biobanking Market focused heavily on various sample types, which play a critical role in the research and development of medical and biological sciences. Blood Products led this segment with a valuation of 1.5 USD Billion in 2024, and it is expected to rise to 2.4 USD Billion by 2035, making it a major player due to the extensive use of blood for diagnostics and therapeutic developments.

Tissues were valued at 1.2 USD Billion in 2024 and are anticipated to grow to 1.9 USD Billion by 2035, reflecting the increasing utilization of tissue samples in regenerative medicine and cancer research. Cells also held a notable position, valued at 1.4 USD Billion in 2024 and projected to reach 2.2 USD Billion in 2035.

The importance of cells, particularly stem cells, in clinical therapies and drug discovery drove their market significance. Nucleic Acids, essential for genetic research and personalized medicine, registered a valuation of 0.8 USD Billion in 2024 and are expected to expand to 1.3 USD Billion by 2035, showcasing the growing focus on genomics.

Meanwhile, Microbiome Samples, while the least valued at 0.24 USD Billion in 2024, are projected to see a slight decrease to 0.2 USD Billion in 2035, reflecting evolving research interests in microbiomes and their implications in health and disease.

Each of these sample types presented unique opportunities and challenges within the Biobanking Market, driven by trends in healthcare research, advancements in technologies, and a growing healthcare data management landscape. These segments not only contributed to the overall valuation of the market but also provided invaluable resources for medical breakthroughs and innovations.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Biobanking Market Application Insights

The Biobanking Market, specifically within the Application segment, plays a crucial role in advancing healthcare and research initiatives worldwide. This segment encompasses vital areas such as Research and Development, Clinical Trials, Personalized Medicine, and Regenerative Medicine.

Research and Development is integral as it underpins innovation, providing researchers with critical biological samples for various studies. Clinical Trials are significantly bolstered by biobanks, as they supply essential data that enhances the efficiency and effectiveness of testing new therapies.

Personalized Medicine is gaining momentum, driven by advancements in genetic research that enable tailored patient treatment strategies based on biobanked samples. Regenerative Medicine focuses on creating therapies to restore damaged tissues and organs, emphasizing the importance of biobanking in developing future healthcare solutions.

The Biobanking Market data indicates strong growth opportunities, primarily driven by technological advancements and increased funding for biomedical research, although challenges such as regulatory compliance and ethical concerns persist in this evolving industry.

Biobanking Market End-use Insights

The Biobanking Market is witnessing significant growth, driven by a strong demand across various End-use sectors, primarily in Academic Research Institutions, Biotechnology Companies, Pharmaceutical Companies, and Government Organizations.

Academic Research Institutions play a pivotal role as they utilize biobanks to conduct advanced genetic research and clinical trials, supporting the evolving landscape of personalized medicine. Biotechnology Companies are also major contributors, leveraging biobanking resources to innovate and develop new therapies, which enhances their competitive edge in the industry.

Pharmaceutical Companies increasingly depend on biobanks for drug discovery and validation processes, emphasizing their importance in bringing new therapeutics to market efficiently. Government Organizations support biobank initiatives through funding and regulatory frameworks, facilitating the integration of biobanks into public health strategies.

Together, these sectors represent the backbone of the Biobanking Market, underscoring the relevance of biobanks in advancing healthcare, ensuring compliance, and supporting research initiatives worldwide. The overall market growth is further propelled by increasing investments in healthcare and technological advancements in biobanking procedures.

Biobanking Market Storage Type Insights

Within the market, the Storage Type segment plays a crucial role, encompassing various storage methods essential for the preservation of biological samples. The segment can be defined through methods such as Vapor Phase Storage, Liquid Phase Storage, and Cryopreservation Storage.

Vapor Phase Storage is increasingly gaining traction due to its capacity to maintain samples at ultra-low temperatures, thus ensuring sample integrity over extended periods. Liquid Phase Storage remains a favored choice for various biobanking applications, as it provides stable conditions that allow for a wide range of biological materials to be preserved effectively.

Cryopreservation Storage is critical in the biobanking industry, facilitating long-term storage solutions for cells and tissues while ensuring their viability for research and clinical applications.

The combination of these storage types is vital as they not only meet regulatory requirements but also cater to the evolving needs of research and healthcare sectors, propelling the Biobanking Market growth while addressing demands for high-quality preservation techniques.

Biobanking Market Regional Insights

The Biobanking Market showed substantial regional diversification, with North America leading the way in market value, estimated at 2.3 USD Billion in 2024 and projected to reach 3.5 USD Billion in 2035. This region displayed majority holding, driven by strong Research and Development initiatives and advanced healthcare infrastructure.

Europe followed with a valuation of 1.4 USD Billion in 2024 and 2.1 USD Billion in 2035, where innovative biobanking practices and stringent regulations support the industry's growth. In South America, the market was valued at 0.3 USD Billion in 2024, with an expected rise to 0.5 USD Billion by 2035, reflecting increasing awareness about biobanking and its applications.

Asia Pacific, valued at 0.9 USD Billion in 2024 and 1.4 USD Billion in 2035, showed significant potential as growing investment in biotechnology and healthcare fuels market growth. The Middle East and Africa, although smaller at 0.2 USD Billion in 2024 with an increase to 0.5 USD Billion by 2035, emerged slowly due to government initiatives in improving healthcare services and biobanking facilities.

The nuances across these regions highlighted varied opportunities, challenges, and trends shaping the Biobanking Market dynamics and overall market growth.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Biobanking Market Key Players and Competitive Insights

The Biobanking Market is a rapidly evolving sector with significant competitive dynamics that reflect its importance in healthcare, research, and diagnostics. As biobanks store biological samples essential for developing personalized medicine, drug discovery, and various genetic studies, understanding the competition among key players becomes crucial for stakeholders.

The market is characterized by numerous organizations implementing strategic initiatives such as collaborations, mergers, and acquisitions to enhance their technological capabilities and expand their geographical footprint.

This competitive landscape underscores the importance of innovation and quality in biobanking services and solutions, as companies vie to establish themselves as leaders in this essential industry. Becton Dickinson holds a prominent position in the Biobanking Market, primarily due to its advanced product offerings and strong commitment to innovation.

The company's strengths lie in its technical expertise and comprehensive range of biobanking solutions, which include specialized collection devices, storage systems, and preservation technologies that cater to the needs of various biobanking operations.

Through sustained investments in research and development, Becton Dickinson has successfully integrated cutting-edge technologies into its products, enhancing efficiency and quality in sample handling and preservation.

The company's extensive global reach further solidifies its market presence, establishing it as a trusted provider of biobanking solutions essential for research and clinical applications.

Biolife Solutions operates as a significant player in the Biobanking Market, recognized for its innovative cryopreservation services and solutions. With a focus on high-performance biopreservation media and related products, Biolife Solutions delivers essential tools that support the preservation and transportation of biological samples, thereby sustaining their viability over time.

The company's approach has led to a strong market presence, supported by strategic collaborations and acquisitions to broaden its product portfolio and scale its services across the global landscape.

Biolife Solutions has built a reputation for high-quality standards and reliability in the biobanking sector, making it a preferred partner for researchers and institutions engaged in critical biological studies and regenerative medicine.

Through its continuous focus on technological advancements and customer satisfaction, Biolife Solutions aims to enhance its competitive edge in the evolving landscape of the Biobanking Market.

Key Companies in the Biobanking Market Include

• Becton Dickinson


• Biolife Solutions


• Charles River Laboratories


• BioCision


• Thermo Fisher Scientific


• STEMCELL Technologies


• Reprocell


• VWR Corporation


• USA Biologics


• Procurement Services


• Genomatica


• Asterand Bioscience


• Qiagen


• SigmaAldrich


• Merck KGaA

Biobanking Market Developments

In an effort to increase diversity and advance personalized medicine initiatives, the U.S. National Institutes of Health (NIH) extended the All of Us Research Program in June 2025 to include the biospecimens of 500,000 more individuals.

In order to strengthen domestic sample integrity and supply, Thermo Fisher Scientific stated in May 2025 that it will invest $2 billion to modernize cold-chain and analytical facilities inside its biobanking division in North America.

With £45 million in financing, a partnership led by Genomics England and the UK Medicines and Healthcare Products Regulatory Agency (MHRA) launched Project Genome of Europe in March 2025 with the goal of accelerating pan-EU research collaborations and harmonizing cross-national biobanking standards.

In order to strengthen Asia-Pacific research capacity, AIG Hospital in southern India launched its first regional biobank in November 2024 with the goal of collecting and storing over 100,000 tissue and blood samples over the next ten years.

Initial results showing effective federated learning deployment across biobanks for multiple sclerosis research were released in October 2024 by the Clinnova effort, a cooperation between France, Germany, Switzerland, and Luxembourg, emphasizing privacy protection and interoperability.

The European biobanking network, BBMRI-ERIC, announced in April 2024 that the number of participating institutions had increased by 12%, indicating improved standardization and sample-sharing capabilities. Additionally, around 25% of biobanks in North America explored blockchain initiatives in early 2024 to safeguard data access and sample tracking processes.

Biobanking Market Segmentation Insights

• Biobanking Market Sample Type Outlook
  
  
  
  • Blood Products
  
  
  • Tissues
  
  
  • Cells
  
  
  • Nucleic Acids
  
  
  • Microbiome Samples
  
  
  
  

• Biobanking Market Application Outlook
  
  
  
  • Research and Development
  
  
  • Clinical Trials
  
  
  • Personalized Medicine
  
  
  • Regenerative Medicine
  
  
  
  

• Biobanking Market End-use Outlook
  
  
  
  • Academic Research Institutions
  
  
  • Biotechnology Companies
  
  
  • Pharmaceutical Companies
  
  
  • Government Organizations
  
  
  
  

• Biobanking Market Storage Type Outlook
  
  
  
  • Vapor Phase Storage
  
  
  • Liquid Phase Storage
  
  
  • Cryopreservation Storage
  
  
  
  

• Biobanking Market Regional Outlook
  
  
  
  • North America
  
  
  • Europe
  
  
  • South America
  
  
  • Asia Pacific
  
  
  • Middle East and Africa
  
  
  
  

Report Attribute/Metric	Details
Market Size 2023	4.93(USD Billion)
Market Size 2024	5.14(USD Billion)
Market Size 2035	8.0(USD Billion)
Compound Annual Growth Rate (CAGR)	4.1% (2025 - 2035)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Base Year	2024
Market Forecast Period	2025 - 2035
Historical Data	2019 - 2024
Market Forecast Units	USD Billion
Key Companies Profiled	Becton Dickinson, Biolife Solutions, Charles River Laboratories, BioCision, Thermo Fisher Scientific, STEMCELL Technologies, Reprocell, VWR Corporation, USA Biologics, Procurement Services, Genomatica, Asterand Bioscience, Qiagen, SigmaAldrich, Merck KGaA
Segments Covered	Sample Type, Application, End-use, Storage Type, Regional
Key Market Opportunities	Personalized medicine advancements, Increased funding for research, Growing demand for biobanked samples, Technological innovations in storage, Expansion in emerging markets
Key Market Dynamics	Increasing demand for personalized medicine, Growth in biopharmaceutical research, Advancements in genomic technologies, Rising government investments, Enhanced awareness of precision medicine
Countries Covered	North America, Europe, APAC, South America, MEA